Drug Trial Radar · NCT05128825
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
310
Planned (sponsor's estimate)
Start
Feb 17, 2022
Primary completion
Dec 1, 2026
Study completion Jun 30, 2027
Sponsor
- Lead sponsor
- K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, IncIndustry
- Sponsor type
- Industry
- First posted
- Nov 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-part Phase 2 study to evaluate the efficacy and safety of azenosertib (ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the study will be conducted in subjects whose tumors are Cyclin E1 positive as determined by central review using the Sponsor's investigational clinical trial assay.
Conditions
- High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Interventions
azenosertibDrug
Azenosertib (ZN-c3) will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR) defined by RECIST v1.1 [Part 2]Time frame: Up to approximately 12 months from the enrollment of the last subject
Locations
89 sites in 9 countries. Site status is shown where the registry gives one.
Site 0170-USA Mitchell Cancer Institute
Mobile, Alabama · Recruiting
Site 0143 - HonorHealth
Phoenix, Arizona · Recruiting
Site 0102 - University of Arizona Cancer Center
Tucson, Arizona · Recruiting
Site 0258 - UC San Diego Moores Cancer Center
La Jolla, California · Active not recruiting
Site 0287 - Ridley Tree Cancer Center
Santa Barbara, California · Active not recruiting
Site 0135 - Rocky Mountain Cancer Centers
Lone Tree, Colorado · Recruiting
Site 0158 - Hartford HealthCare
Hartford, Connecticut · Recruiting
Site 0241 - Florida Cancer Specialist - North
Altamonte Springs, Florida · Recruiting
Site 0173 - Mount Sinai Medical Center
Miami Beach, Florida · Recruiting
Site 0308 - Advent Health
Orlando, Florida · Recruiting
Site 0239 - Florida Cancer Specialists - East
Wellington, Florida · Recruiting
Site 0108 - Emory University Hospital
Atlanta, Georgia · Recruiting
Site 0236 - Memorial Health
Savannah, Georgia · Active not recruiting
Site 0324 - Illinois Cancer Specialists
Niles, Illinois · Active not recruiting
Site 0284 - Community Cancer Center North
Indianapolis, Indiana · Recruiting
Site 0217 - St Vincent Hospital and Health Care Centers
Indianapolis, Indiana · Recruiting
Site 0251 - Norton Cancer Institute
Louisville, Kentucky · Recruiting
Site 0146 - Maryland Oncology Hematology, PA
Rockville, Maryland · Active not recruiting
Site 0221 - Tufts Medical Center - PPDS
Boston, Massachusetts · Recruiting
Site 0104 - Dana Farber Cancer Institute
Boston, Massachusetts · Recruiting
Site 0307 - Lahey Hospital and Medical Center
Burlington, Massachusetts · Recruiting
Site 0263 - Baystate Medical Center
Springfield, Massachusetts · Recruiting
Site 0101 - Barbara Ann Karmanos Cancer Institute
Detroit, Michigan · Recruiting
Site 0228 - Corewell Health Medical Group West
Grand Rapids, Michigan · Recruiting
Site 0288 - Minnesota Oncology Hematology - Maplewood
Maplewood, Minnesota · Recruiting
Site 0226 - CoxHealth
Springfield, Missouri · Active not recruiting
Site 0317 - Nebraska Methodist Hospital
Omaha, Nebraska · Active not recruiting
Site 0213 - Center of Hope
Reno, Nevada · Recruiting
Site 0231 - Northwell Health Cancer Institute
Manhasset, New York · Active not recruiting
Site 0126 - Wilmot Cancer Center
Rochester, New York · Recruiting
Site 0259 - Duke Cancer Center
Durham, North Carolina · Recruiting
Site 0147 - Trihealth Cancer Institute - Harold and Eugen
Cincinnati, Ohio · Recruiting
Site 0243 - Mark H Zangmeister Cancer Center
Columbus, Ohio · Recruiting
Site 0214-Ohio State University Comprehensive Cancer Center
Hilliard, Ohio · Recruiting
Site 0316 - Willamette Valley Cancer Institute/Oncology Associates of Oregon
Eugene, Oregon · Recruiting
Site 0232 - University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
Site 0178 - Thomas Jefferson University
Philadelphia, Pennsylvania · Recruiting
Site 0277 - Alliance Cancer Specialist, PC
Wynnewood, Pennsylvania · Active not recruiting
Site 0132 - Avera Cancer Institute
Sioux Falls, South Dakota · Recruiting
Site 0103 - University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
Showing 40 of 89 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.